Tag: gastrointestinal bleeding treatment devices market scope

Uncover key drivers, emerging technologies, and competitive movements shaping the gastrointestinal bleeding treatment devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Gastrointestinal Bleeding Treatment Devices Market And What Value Is Projected For 2029?

The gastrointestinal bleeding treatment devices market size has shown robust growth in recent years. It is anticipated to increase from $0.87 billion in 2024 to $0.92 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.3%. The expansion observed in the past can be ascribed to an aging population, lifestyle factors, developments in healthcare infrastructure, the occurrence of gastrointestinal disorders, and advancements in endoscopy.

The gastrointestinal bleeding treatment devices market is poised for substantial expansion over the coming years. This market is forecasted to attain a value of $1.28 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This expansion throughout the prediction period is propelled by factors such as patient-centric care initiatives, evolving regulatory frameworks, the adoption of telemedicine and remote consultations, a rise in gastrointestinal disorders, and increased healthcare investment. Prominent trends anticipated in this period encompass non-invasive diagnostic technologies, precision medicine approaches, remote monitoring and telehealth solutions, and the application of artificial intelligence and machine learning.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

What Factors Are Boosting The Gastrointestinal Bleeding Treatment Devices Market?

The increasing occurrence of upper gastrointestinal bleeding is expected to fuel the expansion of the gastrointestinal bleeding treatment devices market throughout the projected timeframe. Upper gastrointestinal (GI) bleeding manifests in the esophagus, stomach, or the initial segment of the small intestine, potentially stemming from conditions such as peptic ulcers, esophagitis, enteritis, gastritis, cancer, among other factors. As an illustration, data from the National Institute for Health and Care Excellence indicates that in the UK, the annual incidence of acute upper GI bleeding varies between 84-172 per 100,000 individuals. Moreover, a study published in the National Library of Medicine – National Institutes of Health in 2023 reported that in-hospital mortality rates for upper GI bleeds are approximately 10%. This percentage holds steady for up to one month post-hospitalization for GI bleed. In the long run, three years subsequent to admission, overall mortality rates approach almost 37%.

What Are The Core Segmentation Criteria In The Gastrointestinal Bleeding Treatment Devices Market?

The gastrointestinal bleeding treatment devicesmarket covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Which Emerging Trends Are Reshaping The Gastrointestinal Bleeding Treatment Devices Market Landscape?

Leading companies in the gastrointestinal bleeding treatment devices market are prioritizing the development of sophisticated solutions, such as the EVIS X1 endoscopy system, to heighten diagnostic accuracy, improve patient outcomes, and streamline clinical operations. The EVIS X1 endoscopy system is a state-of-the-art endoscopic imaging platform engineered to elevate diagnostic precision and therapeutic interventions across various medical fields, including gastroenterology, pulmonology, and urology. For instance, in November 2023, Olympus Corporation, a Japan-based provider of medical and surgical technologies, unveiled its advanced next-generation EVIS X1 endoscopy system. This next-generation EVIS X1 endoscopy system marks a significant advancement in endoscopic imaging technology, designed to boost diagnostic capabilities, enhance procedural efficiency, and facilitate improved clinical results. This latest version of the EVIS X1 expands upon its predecessor by incorporating advanced imaging techniques, intuitive user interfaces, and artificial intelligence (AI) support, tailored for a broad spectrum of medical applications, particularly in gastroenterology and pulmonology.

Which Players Are Shaping The Competitive Landscape Of The Gastrointestinal Bleeding Treatment DevicesXX Market?

Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What Regional Trends Are Shaping Growth In The Gastrointestinal Bleeding Treatment Devices Market?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2025, By The Business Research Company

Wearable Blood Pressure Monitors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Conjugated Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/conjugated-monoclonal-antibodie-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Gastrointestinal Bleeding Treatment Devices Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there has been robust growth in the market size of devices used to treat gastrointestinal bleeding. The value will scale up from $0.87 billion in 2024 to $0.92 billion in 2025, showing a compound annual growth rate (CAGR) of 5.3%. The growth in the past can be accredited to factors such as an expanding elderly population, changing lifestyle patterns, developments in healthcare facilities, prevalence of gastrointestinal conditions, and advancements in endoscopy procedures.

In the coming years, substantial growth is anticipated in the market size of gastrointestinal bleeding treatment devices. It’s predicted that the market will reach a value of $1.28 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.7%. This expected growth can be connected to several factors, such as patient-focused treatments, regulatory shifts, the use of telehealth and remote consultations, a rise in gastrointestinal disorders, and investments in healthcare. The market trends to watch in the forecast period involve non-invasive diagnostic technologies, precision medicine, remote monitoring with telehealth, and the application of artificial intelligence and machine learning.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Gastrointestinal Bleeding Treatment Devices Market?

Increased occurrences of bleeding in the upper gastrointestinal tract are expected to bolster the growth of the market for gastrointestinal bleeding treatment devices for the foreseeable future. Upper gastrointestinal bleeding, which can happen in the esophagus, stomach, or the first section of the small intestine, can be caused by a range of conditions such as peptic ulcers, esophagitis, gastritis, enteritis, cancer, among others. For example, data from the UK’s National Institute for Health and Care Excellence indicate that the incidence of severe upper GI bleeding is between 84-172 per 100,000 people annually. Moreover, research from the National Library of Medicine – National Institutes of Health stated in 2023 that the in-patient mortality rate for upper GI bleeds is around 10%. This statistic stays stable for a month after a GI bleed hospitalization. In the long-run, mortality rates from all causes surge to nearly 37%, three years after being admitted.

Which Key Market Segments Comprise the Gastrointestinal Bleeding Treatment Devices Market and Drive Its Revenue Growth?

The gastrointestinal bleeding treatment devicesmarket covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

Which Areas Are Leading Regions in the Gastrointestinal Bleeding Treatment Devices Market Expansion Across the Globe?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theGastrointestinal Bleeding Treatment Devices Market Direction?

In an attempt to bolster diagnostic accuracy, improve patient results, and simplify clinical operations, top businesses in the gastrointestinal hemorrhage treatment devices field are concentrating on creating advanced systems, such as the EVIS X1 endoscopy machine. This sophisticated endoscopic imaging framework, the EVIS X1 endoscopy system, is intended to enhance diagnostic correctness and therapeutic interventions in several medical disciplines, which include gastroenterology, pulmonology, and urology. For example, Olympus Corporation, a Japan-based medical and surgical technologies organization, introduced its advanced next-generation EVIS X1 endoscopy system in November 2023. This newest version of the EVIS X1 is an evolved revolution in endoscopic imaging technology, constructed to amplify diagnostic potential, maximize procedural productivity, and foster improved clinical outcomes. The updated EVIS X1 enhances its previous version by integrating innovative imaging techniques, user-friendly control panels, and artificial intelligence (AI) assistance, specifically designed to cater to a plethora of medical uses, majorly in gastroenterology and pulmonology.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

How Is the Gastrointestinal Bleeding Treatment Devices Market Conceptually Defined?

Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds. The bleeding could occur anywhere in the gastrointestinal system, including the large intestine, anus, esophagus, small intestine, rectum, and stomach.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Gastrointestinal Bleeding Treatment Devices Market Grown from 2024 to 2025?

The market for devices used in the treatment of gastrointestinal bleeding has seen significant expansion in the past few years. It is projected to increase from a size of $0.87 billion in 2024 to $0.93 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.1%. This growth during the past period is a result of various factors including an aging population, lifestyle habits, development in healthcare facilities, prevalence of gastrointestinal diseases, and advancements in endoscopic procedures.

What Growth Rate Is Anticipated for the Gastrointestinal Bleeding Treatment Devices Market in the Coming Years?

The market for devices treating gastrointestinal bleeding is projected to experience robust growth in the near future, with the expectation of reaching a market value of $1.3 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 8.9%. The projected growth in the forecast period can be linked to factors such as patient-focused treatments, regulatory alterations, advancements in telemedicine, and remote consultations, an increase in gastrointestinal disorders, and an uptick in healthcare investment. Notable trends anticipated during this period include non-invasive diagnostic technologies, precision medicine, remote patient monitoring and telehealth, as well as the integration of artificial intelligence and machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Who Are the Leading Companies in the Gastrointestinal Bleeding Treatment Devices Market?

Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

What Are the Key Drivers of the Gastrointestinal Bleeding Treatment Devices Market?

The increasing instances of upper gastrointestinal bleeding are expected to drive the growth of the market for gastrointestinal bleeding treatment devices in the coming years. Upper gastrointestinal (GI) bleeding takes place in the esophagus, stomach, or upper section of the small intestine and may be a result of various conditions such as peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, the UK’s National Institute for Health and Care Excellence has noted that the annual rate of acute upper GI bleeding ranges from 84-172 for every 100,000 population. Additionally, research published in the National Library of Medicine – National Institutes of Health in 2023, says that in-hospital death rates for upper GI bleeds are approximately 10%. This figure remains constant for one month following hospitalization due to a GI bleed. Looking at the long term, mortality rates from all reasons rise to nearly 37% three years post-admission.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

What Are the Key Market Segments in the Gastrointestinal Bleeding Treatment Devices Industry?

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

What Are the Latest Trends in the Gastrointestinal Bleeding Treatment Devices Market?

Prominent companies within the gastrointestinal bleeding treatment devices market are concentrating on innovating advanced solutions, like the EVIS X1 endoscopy system, to augment diagnostic precision, increase the quality of patient results, and make clinical workflows more efficient. Specifically created to boost diagnostic accuracy and therapeutic treatments in various medical sectors, such as gastroenterology, pulmonology, and urology, the EVIS X1 endoscopy system represents a significant enhancement in endoscopic imaging technology. In November 2023, Olympus Corporation, a Japanese firm known for medical and surgical technologies, introduced its latest next-generation EVIS X1 endoscopy system. This new edition of EVIS X1 further develops its earlier concept by integrating pioneering imaging approaches, intuitive user interfaces, and the benefits of artificial intelligence (AI). This makes it a comprehensive solution for diverse medical uses, particularly in gastroenterology and pulmonology.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What Are the Key Regional Markets in the Gastrointestinal Bleeding Treatment Devices Industry?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

This Report Delivers Insight On:

1. How big is the gastrointestinal bleeding treatment devices market, and how is it changing globally?

2. Who are the major companies in the gastrointestinal bleeding treatment devices market, and how are they performing?

3. What are the key opportunities and risks in the gastrointestinal bleeding treatment devices market right now?

4. Which products or customer segments are growing the most in the gastrointestinal bleeding treatment devices market?

5. What factors are helping or slowing down the growth of the gastrointestinal bleeding treatment devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Bleeding Treatment Devices Market?

The increase in cases of upper gastrointestinal bleeding is expected to stimulate the expansion of the gastrointestinal bleeding treatment devices market throughout the projection period. Upper gastrointestinal (GI) bleeding, which occurs in the esophagus, stomach, or upper segment of the small intestine, can be induced by various circumstances including peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, based on the National Institute for Health and Care Excellence data in the UK, the occurrence rate of acute upper GI bleeding spans between 84-172 per 100,000 population annually. Moreover, a research published in the National Library of Medicine – National Institutes of Health in 2023 reported that in-hospital death rates for upper GI bleeds are approximately 10%, a figure that remains steady for up to a month post-hospitalization for GI bleed. Over an extended period, the mortality rates from all causes almost reach 37% three years post-admission.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

#What is the Growth Potential of the Gastrointestinal Bleeding Treatment Devices Market, and How Will It Perform by 2034?

In recent times, there has been a notable expansion in the market size of gastrointestinal bleeding treatment devices. The market is forecasted to rise from a worth of $0.87 billion in 2024 to an estimated $0.93 billion in 2025, marking a compound annual growth rate (CAGR) of 6.1%. The growth observed during the historic period can be linked to factors such as an aging population, lifestyle influences, developments in healthcare infrastructure, the prevalence of gastrointestinal disorders, and advancements in endoscopy techniques.

The market for gastrointestinal bleeding treatment devices is predicted to witness robust expansion in the coming years, reaching a valuation of $1.3 billion by 2029, at a compound annual growth rate (CAGR) of 8.9%. This growth anticipated during the forecast period can be credited to factors such as patient-focused care, alterations in regulations, the adoption of telemedicine and remote consultations, the rise in gastrointestinal disorders, and investments in healthcare. Innovations influencing this trend include non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth developments, and the implementation of artificial intelligence and machine learning.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

What Are the Latest Innovations Influencing the Gastrointestinal Bleeding Treatment Devices Market?

Key businesses in the market for equipment used in treating gastrointestinal bleeding are forging ahead with the development of innovative solutions such as the EVIS X1 endoscopy system. This is aimed at increasing diagnostic precision, enhancing patient results, and optimizing clinical procedures. The EVIS X1 is an augmented endoscopic imaging platform designed to enhance diagnostic and therapeutic intervention across numerous fields of medicine, notably gastroenterology, pulmonology, and urology. For instance, in November 2023, Olympus Corporation, a leading Japanese company in medical and surgical technologies, released its advanced next-generation EVIS X1 endoscopy system. This new iteration of the EVIS X1, a progressive breakthrough in endoscopic imaging technology, is designed to enhance diagnostic potential and procedural efficiency, and provide better clinical outcomes. Further improvements to the original EVIS X1 system include enhanced imaging techniques, user-centered interfaces, and artificial intelligence (AI) backing, adapted to serve a broad array of medical applications, with a primary focus on gastroenterology and pulmonology.

Who Are the Major Industry Players Accelerating Growth in theGastrointestinal Bleeding Treatment Devices Market?

Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Which Primary Segments of the Gastrointestinal Bleeding Treatment Devices Market Are Driving Growth and Industry Transformations?

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Bleeding Treatment Devices Market?# Market?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Gastrointestinal Bleeding Treatment Devices Maret 2025, By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Gastrointestinal Bleeding Treatment Devices Market From 2025 to 2034?

There has been robust growth in the market size of devices used for treating gastrointestinal bleeding in the recent past. The market, which was valued at $0.87 billion in 2024, is predicted to expand to $0.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The expansion observed during the historic period can be ascribed to factors such as an aging population, lifestyle habits, developments in healthcare infrastructure, prevalence of gastrointestinal disorders, and advancements in endoscopy.

The market for devices used in treating gastrointestinal bleeding is projected to witness substantial expansion in the upcoming years. The market is expected to reach a value of $1.3 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.9%. This surge during the forecast period is likely due to factors like patient-focused care, amendments in regulations, the rise of telemedicine and remote consultations, an increase in gastrointestinal disorders, and investment in healthcare. Key trends forecasted for this period encompass non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, as well as the integration of artificial intelligence and machine learning.

What Drivers Are Shaping the Growth of the gastrointestinal bleeding treatment devices Market?

The observed increase in the occurrence of upper gastrointestinal bleeding is anticipated to fuel the expansion of the market for gastrointestinal bleeding treatment devices through the forecast era. Upper gastrointestinal (GI) bleeding happens in the esophagus, stomach, or upper section of the small intestine. It can be triggered by peptic ulcers, esophagitis, enteritis, gastritis, cancer, and other issues. For instance, the National Institute for Health and Care Excellence reveals that in the UK, the prevalence of acute upper GI bleeding is estimated to be between 84-172 per 100,000 people each year. Moreover, the National Library of Medicine – National Institutes of Health reported in 2023 that in-hospital mortality rates for upper GI bleeds are around 10%. This percentage remains steady for a month after being hospitalized for a GI bleed. In the long run, approximately three years after admission, death rates from all causes climb to nearly 37%.

Get Your Free Sample of the Global Gastrointestinal Bleeding Treatment Devices Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Gastrointestinal Bleeding Treatment Devices Market?

Major companies operating in the gastrointestinal bleeding treatment devices market include:

• CONMED Corporation_x000D_

• Boston Scientific Corporation_x000D_

• Ovesco Endoscopy AG_x000D_

• Olympus Corporation_x000D_

• Cook Medical_x000D_

How Are Market Trends Revolutionizing the Gastrointestinal Bleeding Treatment Devices Industry in Recent Times?

Major players in the gastrointestinal bleeding treatment devices market are focusing their efforts on developing advanced technologies such as the EVIS X1 endoscopy system. This system aims to increase diagnostic precision, improve patient experience, and make clinical processes more efficient. The advanced imagery of the EVIS X1 endoscopy system is designed to enhance diagnostic accuracy and facilitate therapeutic interventions. Its use extends to various medical disciplines, including gastroenterology, pulmonology, and urology. For example, in November 2023, Olympus Corporation, a Japan-based leader in medical and surgical technologies, introduced its innovative next-generation EVIS X1 endoscopy system. This advanced stage of the EVIS X1 endoscopic imaging technology has been designed to improve diagnostic capabilities, increase procedural efficiency, and promote superior clinical outcomes. The introduction of this new iteration amplifies the strengths of its previous version through the integration of state-of-the-art imaging techniques, user-friendly interfaces, and AI support, customised to meet a broad spectrum of medical applications, particularly within gastroenterology and pulmonology.

Get Instant Access to the Global Gastrointestinal Bleeding Treatment Devices Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What Are the Primary Segments of the Gastrointestinal Bleeding Treatment Devices Market and Their Roles in Growth Dynamics?

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Which Geographic Areas Are Influencing the Growth of the Gastrointestinal Bleeding Treatment Devices Market?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Features of the Gastrointestinal Bleeding Treatment Devices Market?

Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds. The bleeding could occur anywhere in the gastrointestinal system, including the large intestine, anus, esophagus, small intestine, rectum, and stomach.

Browse Through More Similar Reports By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: